GUARDIAN study: Genomic newborn screening using dried blood spots achieved 99.6% sequencing success; 110 true positives missed by traditional screening enabled early intervention for conditions like severe combined immunodeficiency and long QT syndrome.

ja.ma/4h3ppUH

#MedSky

Office colleague has pretty low productivity

FDA Approves Attruby™ (acoramidis) for the Treatment of ATTR-CM: A New Option for Patients The FDA’s approval of Attruby is significant for patients with ATTR-CM, providing them with another effective treatment option.

🚨🎉 BREAKING NEWS: The @fda.gov has approved BridgeBio's Attruby™ (acoramidis) for the treatment of patients with transthyretin amyloid cardiomyopathy (#ATTR-CM).

Learn more: arci.org/attruby-attr...